AJANTPHARM

The quarterly revenue has shown a fluctuating trend, with a noticeable increase from March 2024 (Rs 1,054.08 Crore) to March 2025 (Rs 1,170.41 Crore). Net profit also experienced fluctuations, with the highest value in June 2024 (Rs 245.77 Crore). Earnings per share (EPS) also reflect these ***** yearly data shows a consistent increase in revenue from Rs 2,889.69 Crore in 2021 to Rs 4,648.10 Crore in 2025. Net profit also increased significantly over the years, with a slight dip in 2023. The Debt to Equity ratio has remained at 0.00 consistently over the ***** company had announced an interim dividend of Rs 28 per share (1400%) with effective date of November 6, 2024.